ACSS1 (Acetyl-K642) Polyclonal Antibody

货号：ES8818
价格：面议
点击：1674

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human:K642;Mouse:K635;Rat:K635
别称	Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1)

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Camrelizumab Neutralizing Recombinant Antibody \|抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体)	480
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	255
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	452
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	208
Anti-Golimumab Neutralizing Recombinant Antibody \|抗戈利木单抗中和重组抗体(靶标：戈利木单抗中和抗体)	316
Anti-Infliximab Non-Neutralizing Recombinant Antibody \|抗英夫利昔单抗非中和重组抗体(靶标：英夫利昔单抗非中和抗体)	452
Anti-Infliximab Non-Neutralizing Recombinant Antibody \|抗英夫利昔单抗非中和重组抗体(靶标：英夫利昔单抗非中和抗体)	400
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	491
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	351
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	141
Anti-Infliximab Neutralizing Recombinant Antibody \|抗英夫利昔单抗中和重组抗体(靶标：英夫利昔单抗中和抗体)	315
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	232
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	491
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	385
Anti-Matuzumab Neutralizing Recombinant Antibody \|抗马妥珠单抗中和重组抗体(靶标：马妥珠单抗中和抗体)	358
Anti-Elotuzumab Non-Neutralizing Recombinant Antibody\|抗埃罗妥珠单抗非中和重组抗体(靶标：埃罗妥珠单抗非中和抗体)	499
Anti-Elotuzumab Neutralizing Recombinant Antibody \|抗埃罗妥珠单抗中和重组抗体(靶标：埃罗妥珠单抗中和抗体)	149
Anti-Elotuzumab Neutralizing Recombinant Antibody \|抗埃罗妥珠单抗中和重组抗体(靶标：埃罗妥珠单抗中和抗体)	232
Anti-Oleclumab Neutralizing Recombinant Antibody \|抗奥乐克单抗中和重组抗体(靶标：奥乐克单抗中和抗体)	212
Anti-Oleclumab Neutralizing Recombinant Antibody \|抗奥乐克单抗中和重组抗体(靶标：奥乐克单抗中和抗体)	218